Samuel P. Dickson
Samuel P. Dickson publishes mostly in Statistics and Probability, Neurology and Genetics, on topics such as Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Statistical Methods in Clinical Trials.
- World rank
- #1,332,251 of 7,710,434 ranked researchers
- Rank in United States
- #422,740 of 1,627,098
- Works
- 81
- Citations
- 2.6k
- Citations per work
- 32.7
What does Samuel P. Dickson research?
Samuel P. Dickson's work is mostly in Medicine (26%), Mathematics (12%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3745.3%
- Health Sciences2126.4%
- Medicine2126.4%
- Physical Sciences1011.8%
- Mathematics1011.8%
- Life Sciences78.5%
- Social Sciences68.0%
- 1Statistics and Probability12% of their works
- 2Neurology10% of their works
- 3Genetics8% of their works
- 4Psychiatry and Mental health8% of their works
- 5Economics and Econometrics8% of their works
- 6Physiology8% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Alzheimer's disease research and treatments
- Statistical Methods in Clinical Trials
- Health Systems, Economic Evaluations, Quality of Life
- Genetic Associations and Epidemiology
- Parkinson's Disease Mechanisms and Treatments
- Amyotrophic Lateral Sclerosis Research
- Computational Drug Discovery Methods
Which keywords describe Samuel P. Dickson's research?
The keywords of their largest research topics: Biomarkers, Neurodegeneration, Oxidative Stress, Alzheimer's Disease, Mild Cognitive Impairment, Amyloid Hypothesis, Tau Pathology and Adaptive Designs.
- Molecular Docking
- TDP-43
- Genome-Wide Association
- FUS/TLS
- False Discovery Rate
- Adaptive Designs
- Amyloid Hypothesis
- Alzheimer's Disease
- Neurodegeneration
- Biomarkers
- Oxidative Stress
- Mild Cognitive Impairment
- Tau Pathology
- Cost-effectiveness Analysis
- Quality of Life
- Genetic Variation
- Parkinson's Disease
- a-Synuclein
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Biomarkers302 topics
- Neurodegeneration303 topics
- Oxidative Stress222 topics
- Alzheimer's Disease171 topic
- Mild Cognitive Impairment171 topic
- Amyloid Hypothesis141 topic
- Tau Pathology141 topic
- Adaptive Designs131 topic
- Cost-effectiveness Analysis131 topic
- False Discovery Rate131 topic
- Quality of Life131 topic
- FUS/TLS81 topic
- Genetic Variation81 topic
- Genome-Wide Association81 topic
- Parkinson's Disease81 topic
- TDP-4381 topic
- a-Synuclein81 topic
- Molecular Docking61 topic
- Virtual Screening61 topic
Where does Samuel P. Dickson work?
Samuel P. Dickson's main affiliation in the publication record is TetraLogic Pharmaceuticals (United States), United States.
How many publications and citations does Samuel P. Dickson have?
OpenAlex counts 81 works and 2,647 citations for Samuel P. Dickson, an h-index of 16, ranking #1,332,251 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Samuel P. Dickson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.